Health

Sofdra (Sofpironium) for Sweating Disorder Hyperhidrosis Gets FDA Okay

As temperatures rise this time of year, many of us can expect to start sweating more than we may like to. While perspiration during hot weather is normal, some people have a condition that makes them prone to extreme sweating.

Called hyperhidrosis, this disorder is characterized by perspiration (from the underarms, palms, soles of the feet, head and face, and other areas) beyond what the body requires to regulate internal temperature.

Recently, the U.S. Food and Drug Administration (FDA) approved a new topical prescription treatment for a type of hyperhidrosis that results in excessive underarm sweating. The medication, called Sofdra (sofpironium) topical gel, 12.45 percent, is from Botanix Pharmaceuticals. Sofdra is approved for adults and children ages 9 and up.

Danilo V. Del Campo, MD, a dermatologist and the medical director of Chicago Skin Care, suggests that the medication may be especially effective for some patients because of its precise mechanism of action.

“Sofpironium bromide directly limits sweat production by inhibiting the communication pathway responsible for activating the sweat glands,” says Dr. Del Campo. “Nevertheless, each patient’s response to treatment will invariably differ.”

Hyperhidrosis Is Widespread but Under-Recognized

Sofdra was approved to treat a specific kind of hyperhidrosis called primary axillary hyperhidrosis. Another form of the disorder, called secondary hyperhidrosis, can be caused by certain underlying medical problems or as a side effect of certain drugs.

By some estimates, hyperhidrosis affects as many as 4.8 percent of Americans.

“Despite hyperhidrosis affecting millions, it remains under-recognized primarily due to social stigma and lack of awareness,” says Shoshana Marmon, MD, an assistant professor of dermatology at New York Medical College in Valhalla. “Many individuals feel embarrassed to discuss excessive sweating and may perceive it as a personal or hygiene issue rather than a medical condition.”


Source link

Related Articles

Back to top button